Different conformations of phosphatase and Tensin Homolog, deleted on Chromosome 10 (PTEN) protein within the nucleus and cytoplasm of neurons

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Moncalero, Vera L ^a   Costanzo, Roxana V ^b   Perandones, Claudia ^b,c,d   Radrizzani, Martin ^a  

^a UNIVERSIDAD NACIONAL DE SAN MARTÍN   (Argentina)

^b FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^c Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

^d HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; EPITOPE; OLIGONUCLEOTIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; TENSIN; PEPTIDE; PTEN PROTEIN, HUMAN; PTEN PROTEIN, MOUSE;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; CELL FRACTIONATION; CELL NUCLEUS; CEREBELLUM; CHROMOSOME 10; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; CYTOPLASM; ENZYME STRUCTURE; GENE; GENE DELETION; MOLECULAR RECOGNITION; MOUSE; NERVE CELL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PTEN GENE; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL MEMBRANE; CHEMISTRY; GENETICS; HUMAN; METABOLISM; PROTEIN MOTIF;

AMINO ACID MOTIFS; ANIMALS; CELL MEMBRANE; CELL NUCLEUS; COMBINATORIAL CHEMISTRY TECHNIQUES; CYTOPLASM; EPITOPES; HUMANS; MICE; MODELS, BIOLOGICAL; NEURONS; OLIGONUCLEOTIDES; PEPTIDES; PROTEIN CONFORMATION; PTEN PHOSPHOHYDROLASE;

EID: 79955746108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018857     Document Type: Article

References (47)

1. Stokoe D, (2001) Pten. Curr Biol 11: R502.
2. Myers MP, Stolarov JP, Eng C, Li J, Wang SI, et al. (1997) P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A 94: 9052-9057.
3. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, et al. (1998) The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc Natl Acad Sci U S A 95: 13513-13518.
4. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, et al. (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39.
5. Goberdhan DC, Paricio N, Goodman EC, Mlodzik M, Wilson C, (1999) Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev 13: 3244-3258.
6. Maehama T, Dixon JE, (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378.
7. Di Cristofano A, Pandolfi PP, (2000) The multiple roles of PTEN in tumor suppression. Cell 100: 387-390.
8. Blanco-Aparicio C, Canamero M, Cecilia Y, Pequeno B, Renner O, et al. (2010) Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models. PloS one 5: e9305.
9. Gil A, Andres-Pons A, Pulido R, (2007) Nuclear PTEN: a tale of many tails. Cell Death Differ 14: 395-399.
10. Lian Z, Di Cristofano A, (2005) Class reunion: PTEN joins the nuclear crew. Oncogene 24: 7394-7400.
11. Li AG, Piluso LG, Cai X, Wei G, Sellers WR, et al. (2006) Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 23: 575-587.
12. Deleris P, Gayral S, Breton-Douillon M, (2006) Nuclear Ptdlns(3,4,5)P3 signaling: an ongoing story. J Cell Biochem 98: 469-485.
13. Lindsay Y, McCoull D, Davidson L, Leslie NR, Fairservice A, et al. (2006) Localization of agonist-sensitive PtdIns(3,4,5)P3 reveals a nuclear pool that is insensitive to PTEN expression. J Cell Sci 119 (Pt 24): 5160-5168.
14. Lee JO, Yang H, Georgescu MM, Di Cristofano A, Maehama T, et al. (1999) Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: 323-334.
15. Lachyankar MB, Sultana N, Schonhoff CM, Mitra P, Poluha W, et al. (2000) A role for nuclear PTEN in neuronal differentiation. J Neurosci 20: 1404-1413.
16. Perren A, Komminoth P, Saremaslani P, Matter C, Feurer S, et al. (2000) Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol 157: 1097-1103.
17. Whiteman DC, Zhou XP, Cummings MC, Pavey S, Hayward NK, et al. (2002) Nuclear PTEN expression and clinicopathologic features in a population-based series of primary cutaneous melanoma. Int J Cancer 99: 63-67.
18. Deleris P, Bacqueville D, Gayral S, Carrez L, Salles JP, et al. (2003) SHIP-2 and PTEN are expressed and active in vascular smooth muscle cell nuclei, but only SHIP-2 is associated with nuclear speckles. J Biol Chem 278: 38884-38891.
19. Trotman LC, Wang X, Alimonti A, Chen Z, Teruya-Feldstein J, et al. (2007) Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 128: 141-156.
20. Gimm O, Perren A, Weng LP, Marsh DJ, Yeh JJ, et al. (2000) Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol 156: 1693-1700.
21. Tachibana M, Shibakita M, Ohno S, Kinugasa S, Yoshimura H, et al. (2002) Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma. Cancer 94: 1955-1960.
22. Chung JH, Ginn-Pease ME, Eng C, (2005) Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res 65: 4108-4116.
23. Planchon SM, Waite KA, Eng C, (2008) The nuclear affairs of PTEN. J Cell Sci 121 (Pt 3): 249-253.
24. Denning G, Jean-Joseph B, Prince C, Durden DL, Vogt PK, (2007) A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth. Oncogene 26: 3930-3940.
25. Liu F, Wagner S, Campbell RB, Nickerson JA, Schiffer CA, et al. (2005) PTEN enters the nucleus by diffusion. J Cell Biochem 96: 221-234.
26. Liu JL, Mao Z, LaFortune TA, Alonso MM, Gallick GE, et al. (2007) Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Res 67: 11054-11063.
27. Lobo GP, Waite KA, Planchon SM, Romigh T, Houghton JA, et al. (2008) ATP modulates PTEN subcellular localization in multiple cancer cell lines. Hum Mol Genet 17: 2877-2885.
28. Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, et al. (1999) Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol 155: 1253-1260.
29. Ellington AD, Szostak JW, (1990) In vitro selection of RNA molecules that bind specific ligands. Nature 346 (6287): 818-822.
30. Tuerk C, Gold L, (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (4968): 505-510.
31. Weiss S, Proske D, Neumann M, Groschup MH, Kretzschmar HA, et al. (1997) RNA aptamers specifically interact with the prion protein PrP. J Virol 71: 8790-8797.
32. Conti CJ, Larcher F, Chesner J, Aldaz CM, (1988) Polyacrylamide gel electrophoresis and immunoblotting of proteins extracted from paraffin-embedded tissue sections. J Histochem Cytochem 36: 547-550.
33. Fischer MB, Roeckl C, Parizek P, Schwarz HP, Aguzzi A, (2000) Binding of disease-associated prion protein to plasminogen. Nature 408 (6811): 479-483.
34. Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, et al. (2002) Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol 160: 449-457.
35. Moroncini G, Mangieri M, Morbin M, Mazzoleni G, Ghetti B, et al. (2006) Pathologic prion protein is specifically recognized in situ by a novel PrP conformational antibody. Neurobiol Dis 23: 717-724.
36. Perandones C, Costanzo RV, Kowaljow V, Pivetta OH, Carminatti H, et al. (2004) Correlation between synaptogenesis and the PTEN phosphatase expression in dendrites during postnatal brain development. Brain Res Mol Brain Res 128: 8-19.
37. Wang JH, Reinherz EL, (2002) Structural basis of T cell recognition of peptides bound to MHC molecules. Mol Immunol 38: 1039-1049.
38. Baker SJ, (2007) PTEN enters the nuclear age. Cell 128: 25-28.
39. Djordjevic M, (2007) SELEX experiments: New prospects, applications and data analysis in inferring regulatory pathways. Biomol Eng 24: 179-189.
40. Radrizzani M, Broccardo M, Gonzalez Solveyra C, Bianchini M, Reyes GB, et al. (1999) Oligobodies: bench made synthetic antibodies. Medicina (B Aires) 59: 753-758.
41. Radrizzani M, Brocardo MG, Gonzalez Solveyra C, Bianchini M, Reyes GB, et al. (2000) Development of monoclonal oligobodies and chemically synthesized oligobodies. Medicina (B Aires) 60 (Suppl 2): 55-60.
42. White R, Rusconi C, Scardino E, Wolberg A, Lawson J, et al. (2001) Generation of species cross-reactive aptamers using "toggle" SELEX. Mol Ther 4: 567-573.
43. Zhou XP, Marsh DJ, Hampel H, Mulliken JB, Gimm O, et al. (2000) Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis. Hum Mol Genet 9: 765-768.
44. Zhou XP, Loukola A, Salovaara R, Nystrom-Lahti M, Peltomaki P, et al. (2002) PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol 161: 439-447.
45. Fridberg M, Servin A, Anagnostaki L, Linderoth J, Berglund M, et al. (2007) Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN. Leuk Lymphoma 48: 2221-2232.
46. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, et al. (2008) The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network. Nature 455 (7214): 813-817.
47. Lobo GP, Waite KA, Planchon SM, Romigh T, Nassif NT, et al. (2009) Germline and somatic cancer-associated mutations in the ATP-binding motifs of PTEN influence its subcellular localization and tumor suppressive function. Hum Mol Genet 18: 2851-2862.